Based on a comparison of 9 firms among Czech Pharmaceutical Companies, Bayer Czech Republic generated the highest net profit in 2017 followed by Pfizer Czech Republic and Novartis Czech Republic.
Bayer Czech Republic made a net profit of CZK 106 mil, down 39.4% compared to the previous year. Historically, the firm’s net profit reached an all time high of CZK 175 mil in 2016 and an all time low of CZK -11.8 mil in 2007. The average profit in the last five years amounted to CZK 121 mil.
The company generated an average return on equity of 41.9% for its shareholders in the last five years with a maximum of 57.6% and a minimum of 27.2%.
Comparing Bayer Czech Republic with its closest peers, Pfizer Czech Republic generated a net profit of CZK 103 mil with a ROE of 7.86% in 2017, Novartis Czech Republic netted CZK 71.0 mil (ROE of 11.5%) and GlaxoSmithKline Czech Republic announced a net profit of CZK 65.4 mil giving a ROE of 4.30%.
|Roche Czech Republic||CZK mil||50.5||38.7||135||94.9||51.0||...|
|Merck Czech Republic||CZK mil||49.3||63.4||27.4||34.9||68.6|
|Amgen Czech Republic||CZK mil||46.2||28.3||28.7||40.5||35.8|
|Pfizer Czech Republic||CZK mil||231||48.1||144||134||75.4|
|Bayer Czech Republic||CZK mil||166||83.4||96.2||107||123|
|GlaxoSmithKline Czech Republic||CZK mil||240||164||127||87.7||125|
|Sanofi-Aventis Czech Republic||CZK mil||55.1||45.2||65.2||1.19||58.6|
|Novartis Czech Republic||CZK mil||41.7||50.0||52.3||82.2||82.7|
|Servier Czech Republic||CZK mil||...||...||12.8||13.6||13.6||15.9|